Home
About
Publications Trends
Recent Publications
Expert Search
Archive
sensitivity
How is Sensitivity Measured?
Sensitivity is measured by the proportion of true positive cases identified by the test out of the total actual positive cases. The formula is:
Sensitivity = (True Positives) / (True Positives + False Negatives)
For example, if a test identifies 80 out of 100 true cases of
breast cancer
and misses 20, the sensitivity would be 80%.
Frequently asked queries:
What is Sensitivity in Cancer?
Why is Sensitivity Important?
How is Sensitivity Measured?
How is cancer staging conducted?
How are Bone Lesions Related to Cancer?
What is High-Quality Media in Cancer Care?
How can enhancing the quality of data improve cancer research?
What Role Does Funding Play in Developing New Treatments?
What is the Role of Wound Care?
What is Extensive Documentation in Cancer?
Can Yoga Improve Mental Health During Cancer Treatment?
How Are Cancer Models Used in Drug Development?
Are There Nutrients That May Increase Cancer Risk?
What is the Donation Process?
Why Does Bone Marrow Suppression Occur in Cancer Patients?
Why are Novel Contrast Agents Important in Cancer Diagnosis?
What Safety Measures are Recommended?
Can Proliferation Be Targeted for Cancer Therapy?
Why is Proximity to Treatment Important?
Are There Any Scientific Studies Supporting Mindfulness for Cancer Patients?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe